Zenpenta-DSR Capsule is a combination pharmaceutical formulation containing Domperidone 30 mg and Pantoprazole 40 mg, designed for the management of gastrointestinal disorders. Domperidone, a peripheral dopamine D2 receptor antagonist, facilitates gastric motility by enhancing the movement of stomach contents into the intestines, thereby alleviating symptoms such as nausea, vomiting, and gastric stasis. Pantoprazole, a proton pump inhibitor, suppresses gastric acid secretion by inhibiting the H+/K+ ATPase enzyme system in the gastric parietal cells, providing effective relief from acid-related conditions including gastroesophageal reflux disease (GERD), erosive esophagitis, and peptic ulcers. The synergistic action of these two agents in Zenpenta-DSR Capsule offers comprehensive management of upper gastrointestinal symptoms by improving motility and reducing acid secretion. This formulation is typically prescribed for patients experiencing dyspepsia, acid reflux, and delayed gastric emptying. It is important to use Zenpenta-DSR Capsule under medical supervision, considering potential contraindications such as hypersensitivity to its components, and caution in patients with cardiac arrhythmias or electrolyte imbalances. Adherence to prescribed dosage and monitoring for adverse effects, including headache, dry mouth, or abdominal discomfort, is essential to ensure therapeutic efficacy and safety.